<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cellular and interpatient <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> and the involvement of different stem and progenitor compartments in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> are challenges for the identification of common pathways contributing to the initiation and maintenance of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Here we used a strategy of parallel transcriptional analysis of phenotypic long-term hematopoietic stem cells (<z:chebi fb="15" ids="50443">HSCs</z:chebi>), short-term <z:chebi fb="15" ids="50443">HSCs</z:chebi>, and granulocyte-monocyte progenitors from individuals with high-risk (-7/7q-) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and compared them with the corresponding cell populations from healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>This analysis revealed dysregulated expression of 11 genes, including IL-1 receptor accessory protein (IL1RAP), in <z:hpo ids='HP_0000001'>all</z:hpo> leukemic stem and progenitor cell compartments </plain></SENT>
<SENT sid="3" pm="."><plain>IL1RAP protein was found to be overexpressed on the surface of <z:chebi fb="15" ids="50443">HSCs</z:chebi> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients, and marked cells with the -7/7q- anomaly </plain></SENT>
<SENT sid="4" pm="."><plain>IL1RAP was also overexpressed on <z:chebi fb="15" ids="50443">HSCs</z:chebi> of patients with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and high-risk <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, suggesting a pervasive role in different disease subtypes </plain></SENT>
<SENT sid="5" pm="."><plain>High IL1RAP expression was independently associated with poor overall survival in 3 independent cohorts of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients (P = 2.2 Ã— 10(-7)) </plain></SENT>
<SENT sid="6" pm="."><plain>Knockdown of IL1RAP decreased clonogenicity and increased cell <z:hpo ids='HP_0011420'>death</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Our study identified genes dysregulated in stem and progenitor cells in -7/7q- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, and suggests that IL1RAP may be a promising therapeutic and prognostic target in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and high-risk <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
</text></document>